Literature DB >> 16937775

Racial (black-white) contrasts of risk for hypertensive disease in youth have implications for preventive care: the Bogalusa Heart Study.

Gerald Berenson1, Sathanur Srinivasan, Wei Chen, Shengxu Li, Dharmendrakumar Patel.   

Abstract

Cardiovascular (CV) diseases remain the major cause of illness and death in the United States. Adverse CV outcomes are influenced by race/ ethnicity and sex. Race and sex contrasts of CV risk factors become evident early in life and have implications for prevention and medical care. Changes in the CV system in hypertensive disease are mediated by interplay among body fatness, insulin sensitivity, and other factors such as renin-angiotensin system and electrolyte homeostasis. Observations from the Bogalusa Heart Study found higher blood pressure levels in Black children even without obesity, renin as a component of the metabolic/insulin resistance syndrome mainly in Whites, and Black-White differences in electrolyte handling, eg, lower urinary excretion of potassium in Blacks. Understanding divergences in hemodynamic and metabolic parameters for developing hypertensive disease can help improve approaches to beginning prevention at an early age. The use of low doses of antihypertensive medications along with prudent diet and physical activity may be considered for children with elevated blood pressure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937775

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  11 in total

1.  Racial differences in potassium homeostasis in response to differences in dietary sodium in girls.

Authors:  Cristina Palacios; Karin Wigertz; Berdine R Martin; Michelle Braun; J Howard Pratt; Munro Peacock; Connie M Weaver
Journal:  Am J Clin Nutr       Date:  2009-12-09       Impact factor: 7.045

2.  Lifecourse social conditions and racial and ethnic patterns of cognitive aging.

Authors:  M Maria Glymour; Jennifer J Manly
Journal:  Neuropsychol Rev       Date:  2008-09-25       Impact factor: 7.444

3.  Meal patterns and food choices of young African-American men: understanding eating within the context of daily life.

Authors:  Margaret R Savoca; Tara L Martine; Tiffany B Morton; Lakeisha T Johnson; Nancy M Bell; Robert E Aronson; Debra C Wallace
Journal:  J Am Diet Assoc       Date:  2011-09

4.  Effects of obesity and race on left ventricular geometry in hypertensive children.

Authors:  Cozumel S Pruette; Barbara A Fivush; Joseph T Flynn; Tammy M Brady
Journal:  Pediatr Nephrol       Date:  2013-05-24       Impact factor: 3.714

5.  Genetic and environmental risks for high blood pressure among African American mothers and daughters.

Authors:  Jacquelyn Y Taylor; Rosanna Maddox; Chun Yi Wu
Journal:  Biol Res Nurs       Date:  2009-06-01       Impact factor: 2.522

6.  Aldosterone contributes to elevated left ventricular mass in black boys.

Authors:  Diana G Murro; Melinda Beavers; Gregory A Harshfield; Gaston K Kapuku
Journal:  Pediatr Nephrol       Date:  2012-11-24       Impact factor: 3.714

7.  Body Mass Index Drives Changes in DNA Methylation: A Longitudinal Study.

Authors:  Dianjianyi Sun; Tao Zhang; Shaoyong Su; Guang Hao; Tao Chen; Quan-Zhen Li; Lydia Bazzano; Jiang He; Xiaoling Wang; Shengxu Li; Wei Chen
Journal:  Circ Res       Date:  2019-09-12       Impact factor: 17.367

8.  Identifying elevated blood pressure and hypertension in children and adolescents.

Authors:  Shengxu Li; Wei Chen
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-02-12       Impact factor: 3.738

9.  Cigarette smoking exacerbates the adverse effects of age and metabolic syndrome on subclinical atherosclerosis: the Bogalusa Heart Study.

Authors:  Shengxu Li; Miaoying Yun; Camilo Fernandez; Jihua Xu; Sathanur R Srinivasan; Wei Chen; Gerald S Berenson
Journal:  PLoS One       Date:  2014-05-02       Impact factor: 3.240

Review 10.  Prompt, aggressive BP lowering in high-risk patients.

Authors:  Kenneth A Jamerson; Jan Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-01       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.